TAP Lupron Depot Patent Defense Going To Trial; Oakwood Countersues
Executive Summary
TAP's defense of 12 Lupron Depot formulation patents in a suit brought against the generic firm Oakwood Labs is set for a jury trial beginning April 8.
You may also be interested in...
TAP To Audit Marketing Documents Related To Top Lupron, Prevacid Buyers
TAP Pharmaceuticals' corporate integrity agreement with the HHS Inspector General calls for annual audits of the sales and marketing documents related to transactions with the largest volume purchasers of Lupron and Prevacid.
Baxter Buying Asta Medica Oncology: Product-Line Expansion Planned
Baxter plans to expand manufacturing at Asta Medica Oncology's German manufacturing plants via in-licensing and contract manufacturing agreements.
FTC Hytrin Order Clears Path For Four Generics; Cardizem CD Case Filed
Geneva's settlement with the Federal Trade Commission regarding generic terazosin (Hytrin) could open up the market for up to four new entrants.